APA

Galocha B., Hill A., Barnett B. C., Dolan A., Raimondi A., Cook R. F., Brunner J., McGeoch D. J. & Ploegh H. L. (19970602). The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. : The Journal of experimental medicine.

Chicago

Galocha B, Hill A, Barnett B C, Dolan A, Raimondi A, Cook R F, Brunner J, McGeoch D J and Ploegh H L. 19970602. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. : The Journal of experimental medicine.

Harvard

Galocha B., Hill A., Barnett B. C., Dolan A., Raimondi A., Cook R. F., Brunner J., McGeoch D. J. and Ploegh H. L. (19970602). The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. : The Journal of experimental medicine.

MLA

Galocha B, Hill A, Barnett B C, Dolan A, Raimondi A, Cook R F, Brunner J, McGeoch D J and Ploegh H L. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. : The Journal of experimental medicine. 19970602.